HSBC Holdings
RIGL icon

HSBC Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

HSBC Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Buy
18,577
+4,716
+34% +$145K ﹤0.01% 2092
2026
Q1 		$374K Buy
13,861
+1,417
+11% +$47.6K ﹤0.01% 2357
2025
Q4 		$537K Buy
12,444
+1,882
+18% +$70.9K ﹤0.01% 2280
2025
Q3 		$302K Buy
+10,562
New +$316K ﹤0.01% 2330
2024
Q2 		– Sell
-8,483
Closed -$126K – 3137
2024
Q1 		$126K Buy
8,483
+6,373
+302% +$85.9K ﹤0.01% 2802
2023
Q4 		$31.2K Hold
2,110
– – ﹤0.01% 2674
2023
Q3 		$22.7K Buy
2,110
+13
+0.6% +$156 ﹤0.01% 2667
2023
Q2 		$27.3K Hold
2,097
– – ﹤0.01% 2511
2023
Q1 		$27.9K Buy
+2,097
New +$33.3K ﹤0.01% 2592
2021
Q2 		– Sell
-7,882
Closed -$269K – 3056
2021
Q1 		$269K Sell
7,882
-11,363
-59% -$450K ﹤0.01% 2368
2020
Q4 		$679K Hold
19,245
– – ﹤0.01% 1974
2020
Q3 		$465K Sell
19,245
-2,413
-11% -$59.2K ﹤0.01% 1990
2020
Q2 		$396K Buy
21,658
+6,057
+39% +$109K ﹤0.01% 1985
2020
Q1 		$243K Buy
15,601
+62
+0.4% +$1.32K ﹤0.01% 2180
2019
Q4 		$336K Sell
15,539
-1,731
-10% -$35.6K ﹤0.01% 2471
2019
Q3 		$323K Buy
17,270
+16,264
+1,617% +$336K ﹤0.01% 2582
2019
Q2 		$26K Sell
1,006
-104
-9% -$2.35K ﹤0.01% 2673
2019
Q1 		$29K Buy
+1,110
New +$25.4K ﹤0.01% 2669
2017
Q1 		– Sell
-1,723
Closed -$41K – 2498
2016
Q4 		$41K Buy
+1,723
New +$49.3K ﹤0.01% 2677

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's RIGL Position: Q2 2026 in Review

HSBC Holdings increased its Rigel Pharmaceuticals (RIGL) stake by 34% in Q2 2026, buying an estimated $145K and bringing the position to 18,577 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

HSBC Holdings first reported a position in RIGL in Q4 2016 and has held it in 19 quarters since. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • HSBC Holdings held 18,577 shares of Rigel Pharmaceuticals worth $745K as of Q2 2026.
  • HSBC Holdings bought 4,716 Rigel Pharmaceuticals shares in Q2 2026, an estimated $145K.
  • Rigel Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2092 holding.
  • HSBC Holdings first reported a position in Rigel Pharmaceuticals in Q4 2016 and has held it in 19 quarters since.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.